Issue of Equity and Total Voting Rights
August 22 2022 - 9:46AM
Issue of Equity and Total Voting Rights
Seneca Growth Capital VCT Plc (the "Company")
22 August 2022
Issue of Equity and Total Voting Rights
The Company announces that it has today allotted
and issued 475,306 new B ordinary shares of 1p each in the Company
(“B Shares”).
The shares were issued pursuant to an offer for
subscription for B Shares launched on 29 October 2021 to
raise, in aggregate, up to £10 million with an over-allotment
facility of up to a further £10 million (before issue costs) (the
"Offer").
Pursuant to the Offer, and the £419,274.86 of
valid applications received since 29 April 2022 (the cut-off date
for the last allotment of shares made on 4 May 2022), and up to and
including 18 August 2022 in respect of the 2022/2023 tax year, the
Company has today allotted and issued 475,306 B Shares. In
accordance with the allotment formula set out in the prospectus for
the Offer, the B Shares have been allotted at the offer prices in
the range of 87.5p to 90.2p per share, calculated by reference to
the unaudited net asset value of a B Share as at 30 June 2022
(87.5p per B Share as announced on 15 July 2022).
As a result of this allotment, the number of
shares now in issue is 8,115,376 ordinary shares of 1p each and
17,570,989 B Shares. Therefore, the total number of voting rights
in the Company is 25,686,365.
In respect of this allotment, an application
will be made by the Company to the Financial Conduct Authority and
to the London Stock Exchange for the B Shares so issued to be
admitted to the Official List and to trading on the London Stock
Exchange's main market for listed securities. It is expected that
the admission of the B Shares will become effective and dealings
will commence on or around 26 August 2022.
The above statement of voting capital may be
used by shareholders as the denominator for the calculations by
which they will determine if they are required to notify their
interest, or a change to their interest, in the Company under the
FCA's Disclosure Guidance and Transparency Rules.
The Offer is now closed to further applications.
The Company announces that under the Offer it received and accepted
valid applications to the value of £3,800,680.20 (before issue
costs).
This announcement contains inside information as
stipulated under the UK version of the Market Abuse Regulation No
596/2014 which is part of English law by virtue of the European
(Withdrawal) Act 2018, as amended. On publication of this
announcement via a regulatory information service, this information
is considered to be in the public domain.
For further information, please contact:
John Hustler, Seneca Growth Capital VCT Plc at
john.hustler@btconnect.com
Richard Manley, Seneca Growth Capital VCT Plc at
Richard.Manley@senecapartners.co.uk
Bioscience Vct (LSE:BVP)
Historical Stock Chart
From Dec 2024 to Jan 2025
Bioscience Vct (LSE:BVP)
Historical Stock Chart
From Jan 2024 to Jan 2025
